LDN may emerge as the first of many glial cell modulators that could be used to treat chronic conditions, with more specifically targeted medications developed in the future
Log meals with a photo, track what sits well, and spot trends over time - with or without a CGM
There are many factors that can contribute to low endogenous glutathione levels
In summary, evidence from animal models, in vitro experimental systems, and clinical observational studies support our hypothesis of a possible correlation between hyperprolactinemia and obesity
The product has generated serious buzz in the gut health and peptide and GLP-1 research community
Omada is uniquely suited to meet this moment as the conversation shifts beyond Can patients get these drugs? to Can we help members use them effectively and safely for long-term outcomes?. Omadas GLP-1 care companion solution can include nutrition guidance, education and a care team of health coaches, cardiometabolic specialists or exercise specialists